TABLE 1.
Member Demographics and Clinical Characteristics
| Oral Antidiabetics, n = 5,421 | Antihypertensives, n = 19,520 | Statins, n = 19,244 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Intervention | Control | P Value | Intervention | Control | P Value | Intervention | Control | P Value | |
| Member count, n | 1,277 | 4,144 | 4,787 | 14,733 | 4,382 | 14,862 | |||
| Female, % | 51.8 | 53.9 | 0.180 | 53.6 | 56.9 | < 0.001 | 51.8 | 54.9 | < 0.001 |
| New to therapy,a % | 21.5 | 22.4 | 0.484 | 20.9 | 20.0 | 0.155 | 21.8 | 19.4 | < 0.001 |
| 90-day refill, % | 59.6 | 70.0 | < 0.001 | 64.4 | 71.6 | < 0.001 | 65.7 | 72.8 | < 0.001 |
| Low-income subsidy, % | 41.4 | 18.9 | < 0.001 | 34.6 | 15.9 | < 0.001 | 32.7 | 16.2 | < 0.001 |
| Age, years, mean (SD) | 71.3 (8.8) | 73.7 (8.7) | < 0.001 | 71.8 (9.2) | 74.6 (8.7) | < 0.001 | 71.3 (8.5) | 73.8 (8.5) | < 0.001 |
| Age group, years, % | < 0.001 | < 0.001 | < 0.001 | ||||||
| < 54 | 4.6 | 3.0 | 4.8 | 2.2 | 3.7 | 2.5 | |||
| 55-64 | 12.9 | 6.8 | 12.0 | 5.5 | 11.9 | 5.4 | |||
| 65-74 | 53.6 | 49.8 | 51.5 | 47.9 | 54.1 | 48.9 | |||
| 75+ | 28.9 | 40.4 | 31.6 | 44.4 | 30.4 | 43.2 | |||
| Number of target medication classes,b % | 0.640 | < 0.001 | 0.090 | ||||||
| 1 | 13.7 | 12.1 | 41.2 | 34.6 | 38.5 | 36.0 | |||
| 2 | 39.2 | 35.3 | 45.4 | 50.0 | 47.0 | 48.5 | |||
| 3 | 47.1 | 52.6 | 13.4 | 15.3 | 14.5 | 15.4 | |||
| Comorbidity count,c % | 0.161 | 0.008 | 0.078 | ||||||
| < 3 | 29.8 | 30.9 | 41.7 | 42.1 | 45.6 | 44.2 | |||
| 3-4 | 40.5 | 40.6 | 35.3 | 35.9 | 31.9 | 34.2 | |||
| 5-6 | 20.8 | 20.5 | 16.7 | 16.0 | 16.1 | 15.4 | |||
| 7-8 | 6.6 | 6.5 | 4.8 | 4.8 | 5.0 | 4.9 | |||
| 9+ | 2.3 | 1.5 | 1.5 | 1.2 | 1.6 | 1.3 | |||
aDefined as absence of prescription claim for targeted medication class in 1-year baseline (preintervention) period.
bMembers could be identified for intervention by more than 1 medication class.
cComorbidity count estimated by Medicaid Rx.